📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39. (2019)

First Author: Spiliopoulou A

Attributed to: Maximising Therapeutic Utility for Rheumatoid Arthritis using genetic and genomic tissue responses to stratify medicines. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2018-214877

PubMed Identifier: 31036624

Publication URI: http://europepmc.org/abstract/MED/31036624

Type: Journal Article/Review

Volume: 78

Parent Publication: Annals of the rheumatic diseases

Issue: 8

ISSN: 0003-4967